Prasugrel is effective and safe for neurointerventional procedures
Authors:
- 22 May 2012
- journal article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 5 (4) , 332-336
Abstract
Background Clopidogrel bisulfate and aspirin are routinely administered as dual antiplatelet agents for many neurointerventional procedures, especially for intravascular stent placement. Many patients are non-responsive to clopidogrel, either secondary to drug interactions or from variations of cytochrome P450 enzymes. Prasugrel (brand name Effient, Eli Lilly and Company, Indianapolis, IN, USA) is a new antiplatelet agent that has been utilized extensively in patients undergoing cardiovascular procedures but its safety and efficacy during neurointerventional procedures have not been evaluated. Objective To examine whether prasugrel is a safe and effective alternative to clopidogrel for neurointerventional procedures, especially in those patients who are either non-responders or allergic to clopidogrel. Methods The medical records of all patients undergoing neurointerventional procedures at our institution who received prasugrel between January 2009 and July 2011 were retrospectively reviewed. A systematic chart review was performed and the following data were recorded: demographics, aneurysm location, endovascular techniques, peri- and post-procedural complications, hemorrhagic complications, clinical outcome and angiographic outcome. Results 16 patients undergoing neurointerventional procedures received prasugrel over a 2 year interval. All patients who had follow-up studies of P2Y12 inhibition had immediate therapeutic response to prasugrel. There were no complications related to ischemic or intracranial hemorrhage. Conclusion Prasugrel is a viable alternative to clopidogrel for patients undergoing neurointerventional procedures who are non-responders to clopidogrel. Further study is needed to evaluate the safety, efficacy and cost-effectiveness of prasugrel compared with clopidogrel for patients undergoing neurointerventional procedures.Keywords
This publication has 34 references indexed in Scilit:
- Long-term MRI findings of patients with embolized cerebral aneurysmsActa Radiologica, 2011
- Is Clopidogrel Premedication Useful to Reduce Thromboembolic Events During Coil Embolization for Unruptured Intracranial Aneurysms?Neurosurgery, 2010
- PrasugrelCirculation, 2010
- Preliminary results of Carotid Revascularization Endarterectomy vs Stenting Trial (CREST)Journal of Vascular Surgery, 2010
- Prevention and Treatment of Thromboembolism during Endovascular Aneurysm Therapy*Clinical Neuroradiology, 2009
- Incidence and Clinical Impact of Dual Nonresponsiveness to Aspirin and Clopidogrel in Patients With Drug-Eluting StentsJACC, 2008
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With AspirinJACC, 2008
- Effect of Antiplatelet Therapy on Thromboembolic Complications of Elective Coil Embolization of Cerebral AneurysmsAmerican Journal of Neuroradiology, 2007
- Clopidogrel Effect on Platelet REactivity in Patients With Stent ThrombosisJACC, 2005
- Electrothrombosis of saccular aneurysms via endovascular approachJournal of Neurosurgery, 1991